PIP for Polymyalgia Rheumatica (PMR) - Can You Claim?

Polymyalgia rheumatica (PMR) causes severe muscle pain and stiffness in the shoulders, neck, upper arms, hips and thighs. It comes on suddenly, often overnight and makes basic movements - lifting your arms above your head, getting out of bed, climbing stairs - extremely difficult. Despite being relatively common in people over 50, PMR is poorly understood by many PIP assessors.

Which PIP Activities Does PMR Affect?

Dressing and Undressing (Activity 6) - This is often the highest-scoring activity. PMR causes severe shoulder stiffness that prevents lifting arms above the head. Putting on tops, bras, coats and jackets becomes impossible without help. Pulling clothing over your head requires arm elevation that PMR specifically prevents. If you need someone to help dress your upper body on most days, this scores 4 points (descriptor 6e).

Washing and Bathing (Activity 4) - Cannot reach to wash hair (arms won't lift high enough). Cannot reach behind to wash back. Cannot reach feet to wash them (hip stiffness). Getting in and out of the bath requires core and hip strength that PMR reduces. If you need help, aids or can't wash certain body parts, this scores.

Preparing Food (Activity 1) - Cannot lift heavy items (pans, plates from high shelves). Shoulder and arm stiffness prevents stirring, chopping and reaching. Morning stiffness lasting 1-3 hours means cooking breakfast is impossible - and that's the meal you're most likely to prepare alone.

Moving Around (Activity 12) - Hip and thigh involvement limits walking distance. Severe morning stiffness means mobility is worst in the first few hours. Stairs become very difficult. If you hold onto furniture and walls to get around the house, describe it.

Managing Therapy (Activity 3) - Prednisolone (often for 1-2+ years) is medication, so needing someone to remind, supervise or help you take it and manage the steroid reduction, or an aid such as a dosette box, scores 1 point (descriptor 3b) however long the course lasts. Blood tests and rheumatology appointments do not count. Steroid side effects (weight gain, mood changes, osteoporosis risk, insomnia, diabetes) are all PIP-relevant.

Steroid Side Effects Matter

Most people with PMR take prednisolone for 1-2 years minimum. The side effects are significant and affect PIP activities independently: weight gain affecting mobility, insomnia causing fatigue, mood swings affecting social engagement, weakened bones increasing falls risk, raised blood sugar requiring monitoring. Describe every side effect on your form.

The Morning Stiffness Problem

PMR stiffness is typically worst in the morning, lasting 1-3 hours before steroids take effect. During this time you may be unable to get out of bed, dress, wash or prepare food without help. PIP assessors sometimes dismiss this because "you improve later in the day." But the reliability criteria require you to do things repeatedly (as often as they are reasonably required) and within a reasonable time (no more than twice as long as someone without your condition would take) - if you cannot dress or wash for the first 3 hours of every day, or it takes you far longer than it should, you are not doing those activities reliably.

PMR and Giant Cell Arteritis

About 15-20% of people with PMR also develop giant cell arteritis (GCA/temporal arteritis). If you have GCA, this adds headaches, jaw pain, visual disturbance and the serious risk of permanent blindness. GCA is a medical emergency and should be described separately on your PIP form as an additional condition.

What Evidence Helps?

• Rheumatologist letters
• Blood test results (ESR, CRP showing inflammation)
• Steroid dose history (showing need for ongoing treatment)
• GP records of steroid side effects
• Partner statement describing morning routine and help needed

PMR Diagnostic Criteria

PMR diagnosis (per EULAR/ACR 2012 criteria) requires:

• Age 50 or older
• New onset bilateral shoulder aching
• Raised ESR or CRP (inflammatory markers)
• At least 4 of: morning stiffness over 45 minutes, hip pain or limited range, absence of rheumatoid factor, absence of other joint involvement

If your rheumatologist used these criteria, ask for a letter confirming. Formal diagnostic letter is gold-standard PIP evidence.

Steroid Side Effects in Detail

Long-term prednisolone (typically used for 1-3 years in PMR) causes:

• Weight gain: Often 5-15kg over treatment course
• Moon face / Cushingoid changes: Facial appearance changes
• Skin thinning: Easy bruising, slow wound healing
• Osteoporosis: Bone thinning. Usually requires bisphosphonates and calcium/vitamin D.
• Steroid-induced diabetes: Up to 25% develop on long-term steroids
• Mood changes: Insomnia, irritability, sometimes depression or psychosis
• Cataract formation: Long-term risk
• Increased infection susceptibility
• Adrenal suppression: Cannot stop suddenly. Withdrawal symptoms common.
• Steroid myopathy: Paradoxically, can cause muscle weakness
• Avascular necrosis: Rare but serious - hip pain from bone death

Document each side effect. They affect multiple PIP activities and add significantly to impact.

Steroid-Sparing Agents

Some PMR patients need steroid-sparing medication if cannot reduce prednisolone:

• Methotrexate (off-label)
• Tocilizumab (newer biologic, NHS access limited)
• Leflunomide

Being on steroid-sparing therapy indicates more severe or refractory PMR.

Giant Cell Arteritis Detail

GCA is a medical emergency. Symptoms include:

• New severe headache, often temporal
• Scalp tenderness
• Jaw claudication (pain on chewing)
• Vision problems - blurred vision, double vision, sudden vision loss
• Fatigue and weight loss
• Fever

Treatment is high-dose steroids (40-60mg prednisolone) urgently to prevent permanent blindness. If you have GCA alongside PMR, list both - the combined impact is substantial and the treatment regimen even more burdensome.

Activity 6 - The Classic PMR Score

PMR shoulder involvement classically affects Activity 6 dressing:

• Descriptor e (4 points): Needs assistance to dress upper body. Very common with PMR.
• Descriptor d (2 points): Needs assistance to dress lower body if hip involvement severe.
• Descriptor b (2 points): Uses aids (front-fastening bras, slip-on shoes, long-handled shoe horn).

Most PMR claimants score at least Activity 6 descriptor b. Many qualify for descriptor d or e.

Frequently Asked Questions

I am responding well to prednisolone - can I still claim?

Yes if you still have functional impact. Most PMR patients still have morning stiffness, fatigue and steroid side effects even on optimal dose. PIP looks at function with medication, not without.

How long will my PMR last?

Typical course is 1-3 years on prednisolone. Some patients have relapses. Around 25% remain on steroids long-term. PIP can be claimed throughout, with award reviewed at end of treatment.

I am over State Pension age - what do I claim?

You cannot start a new PIP claim. Claim Attendance Allowance instead (covers daily living only, no mobility). PMR commonly affects people over 50, including many post-pension-age.

My ESR is normal - does that mean my PMR isn't real?

Around 20% of PMR cases have normal ESR. Treatment response is also diagnostic - if prednisolone dramatically improves symptoms, this supports PMR diagnosis. Normal blood markers do not exclude PMR.

What about PMR relapse during steroid taper?

Common - around 50% of patients relapse during steroid reduction. Each relapse needs steroid dose increase and prolongs treatment. Document relapses as evidence of chronic/severe disease.

Can I get PIP for PMR plus other arthritis?

Yes. Many PMR patients have coexisting OA, RA or other rheumatological conditions. Combined impact qualifies for higher rates. List all conditions on the form.

Will tocilizumab affect my PIP claim?

Being on tocilizumab indicates severe refractory PMR. It is a biologic given by infusion or injection, which counts as medication rather than therapy, so needing help with it scores 1 point at most (descriptor 3b) and hospital infusions do not count under Activity 3. Its main value is as evidence of severity. Most tocilizumab patients continue to qualify for PIP.